当前位置: X-MOL首页 › 最新SCI期刊查询及投稿分析系统 › Drug Development and Industrial Pharmacy杂志
Drug Development and Industrial Pharmacy
基本信息
期刊名称 | Drug Development and Industrial Pharmacy DRUG DEV IND PHARM |
---|---|
期刊ISSN | 0363-9045 |
期刊官方网站 | https://www.tandfonline.com/journals/iddi20 |
是否OA | No |
出版商 | Informa Healthcare |
出版周期 | Monthly |
文章处理费 | 登录后查看 |
始发年份 | |
年文章数 | 83 |
最新影响因子 | 2.4(2023) scijournal影响因子 greensci影响因子 |
中科院SCI期刊分区
大类学科 | 小类学科 | Top | 综述 |
---|---|---|---|
医学4区 | CHEMISTRY, MEDICINAL 药物化学4区 | 否 | 否 |
PHARMACOLOGY & PHARMACY 药学4区 |
CiteScore
CiteScore排名 | CiteScore | SJR | SNIP | ||
---|---|---|---|---|---|
学科 | 排名 | 百分位 | 6.8 | 0.475 | 0.684 |
Pharmacology, Toxicology and Pharmaceutics Pharmaceutical Science |
44/183 | 76% |
|||
Chemistry Organic Chemistry |
54/211 | 74% |
|||
Pharmacology, Toxicology and Pharmaceutics Pharmacology |
96/313 | 69% |
|||
Pharmacology, Toxicology and Pharmaceutics Drug Discovery |
49/157 | 69% |
补充信息
自引率 | 4.2% |
---|---|
H-index | 78 |
SCI收录状况 |
Science Citation Index Expanded |
官方审稿时间 | 登录后查看 |
网友分享审稿时间 | 数据统计中,敬请期待。 |
接受率 | 登录后查看 |
PubMed Central (PMC) | http://www.ncbi.nlm.nih.gov/nlmcatalog?term=0363-9045%5BISSN%5D |
投稿指南
期刊投稿网址 | http://mc.manuscriptcentral.com/lddi |
---|---|
收稿范围 | Drug Development and Industrial Pharmacy is a subscription-based journal publishing novel, original, peer-reviewed research and review manuscripts related to pharmaceutical science research, specifically in the fields of nanomedicines, formulation, development and delivery technologies, biopharmaceuticals, new material development, processing technology advancement, and preclinical, clinical and regulatory evaluation of formulation and delivery technologies. Research papers must be hypothesis driven and emphasize innovative breakthrough topics. Timely critical review papers within the journal scope are also welcomed, alongside data notes, methods, and registered reports. The priority topics for the journal include: i. Nanomedicines ii. New Material Development iii. Advanced Formulation, Development and Delivery Technologies iv. Innovative Processing and Analytical Technologies v. Preclinical and Clinical Evaluation of Formulation Technologies vi. Regulatory Aspects The journal’s audience includes pharmacists, academic and industry scientists (working in the areas of pharmaceutical science, material science, biopharmaceuticals, nanomedicine, pharmaceutical technology), regulatory scientists, pharmacologists, toxicologists, clinicians, medicinal chemists or chemists working in area of designing and developing new materials (i.e. polymers, lipids, excipients), and analytical chemists. All articles received by the Journal will be subject to single-anonymous peer review. |
收录体裁 | |
投稿指南 | https://www.tandfonline.com/action/authorSubmission?show=instructions&journalCode=iddi20 |
投稿模板 | |
参考文献格式 | |
编辑信息 |
我要分享 (欢迎您来完善期刊的资料,分享您的实际投稿经验)